EBDP

EBDP

EBDP (also known as Ethylone or 3,4-Methylenedioxy-N-ethylcathinone) is a psychoactive drug and member of the phenethylamine, amphetamine, and cathinone chemical classes. It is the β-keto analogue of MDMA.

Chemistry

EBDP is a synthetic cathinone. Its chemical name is 3,4-Methylenedioxy-N-ethylcathinone. The formula for EBDP is C12H15NO3. It is a β-keto analogue of MDMA, meaning it shares a similar core amphetamine structure, with an oxygen group (keto) attached to the beta carbon.

Pharmacology

EBDP acts as a mixed reuptake inhibitor/releasing agent of serotonin, norepinephrine, and dopamine. These are the same mechanisms of action used by other psychoactive drugs such as MDMA and amphetamine. The effects of EBDP can include euphoria, increased sociability, mental and physical stimulation, and a perceived increase in emotional sensitivity.

Effects

The effects of EBDP can vary greatly depending on the dose, the user's individual physiology, and the environment in which it's used. Common effects can include feelings of euphoria, increased sociability, and heightened sensory perception. At higher doses, EBDP can cause more intense effects such as visual distortions, hallucinations, and increased heart rate.

Legal Status

The legal status of EBDP varies by country. In the United States, it is a Schedule I controlled substance. In the United Kingdom, it is a Class B drug. In Canada, it is a Schedule I drug. It is also controlled in many other countries under their respective controlled substances acts.

See Also

• MDMA
• Cathinone
• Amphetamine
• Psychoactive drug